KYMR
KYMR
NASDAQ · Biotechnology

Kymera Therapeutics Inc

$117.67
-0.08 (-0.07%)
As of Sep 21, 8:25 PM ET ·
Analyst Consensus
Strong Buy
30
Analysts
Very High
Coverage
Buy 26 87%
Hold 4 13%
Sell 0 0%
Price Target
Analyst Price Target -73.6% upside
Low Target $20.33
Average Target $31.03
High Target $33.62
Current Price $117.67
Current
$117.67
Target
$31.03
$20.33 $31.03 avg $33.62
Scenario Analysis
Bear Case
$20.33
-82.7%
Low target
Base Case
$31.03
-73.6%
Avg target
Bull Case
$33.62
+-71.4%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$130.05
-9.5% from high
52-Week Low
$47.86
+145.9% from low
50-Day SMA
$78.66
+49.6% vs SMA
200-Day SMA
$56.03
+110.0% vs SMA
RSI (14)
77.3
Overbought
Target vs 52W High
$31.03
-76.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.7%
AMGN
Amgen Inc
Hold 43 47% $190.87 -51.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +139.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.3%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.3%
MRNA
Moderna Inc
Hold 30 37% $149.45 -13.8%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -61.5%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -41.0%